Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice - PubMed (original) (raw)
. 2000 Jan 15;95(2):692-9.
Affiliations
- PMID: 10627481
Free article
Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice
S L Gee et al. Blood. 2000.
Free article
Abstract
Alternative splicing plays a major role in regulating tissue-specific expression of cytoskeletal protein 4.1R isoforms. In particular, expression of the protein's functionally critical spectrin-actin binding domain, essential for maintenance of red cell membrane mechanical properties, is governed by a developmentally regulated splicing switch involving alternative exon 16. Using a model 3-exon 4.1R pre-messenger RNA (pre-mRNA), we explored the sequence requirements for excision of the introns flanking exon 16. These studies revealed that splicing of this alternative exon occurs preferentially in an ordered fashion. The first step is excision of the downstream intron to join exons 16 and 17, followed by excision of the upstream intron. Constructs designed to test the converse pathway were spliced less efficiently and with less fidelity, in part due to activation of a cryptic 5' splice site in exon 16. This downstream-first model for ordered splicing is consistent with the hypothesis that regulated alternative splicing requires cooperation between multiple exonic and/or intronic regulatory elements whose spatial organization is critical for recruitment of appropriate splicing factors. Our results predict that exon 16 splicing is regulated at the first step-excision of the downstream intron-and that cells unable to catalyze this step will exhibit exon 16 skipping. In cells that include exon 16, adherence to an ordered pathway is important for efficient and accurate production of mature 4.1R mRNA encoding an intact spectrin-actin binding domain. (Blood. 2000;95:692-699)
Similar articles
- Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.
Hou VC, Lersch R, Gee SL, Ponthier JL, Lo AJ, Wu M, Turck CW, Koury M, Krainer AR, Mayeda A, Conboy JG. Hou VC, et al. EMBO J. 2002 Nov 15;21(22):6195-204. doi: 10.1093/emboj/cdf625. EMBO J. 2002. PMID: 12426391 Free PMC article. - Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.
Deguillien M, Huang SC, Morinière M, Dreumont N, Benz EJ Jr, Baklouti F. Deguillien M, et al. Blood. 2001 Dec 15;98(13):3809-16. doi: 10.1182/blood.v98.13.3809. Blood. 2001. PMID: 11739190 - Alternative 5' exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini.
Parra MK, Gee SL, Koury MJ, Mohandas N, Conboy JG. Parra MK, et al. Blood. 2003 May 15;101(10):4164-71. doi: 10.1182/blood-2002-06-1796. Epub 2003 Jan 9. Blood. 2003. PMID: 12522012 - The role of alternative pre-mRNA splicing in regulating the structure and function of skeletal protein 4.1.
Conboy J. Conboy J. Proc Soc Exp Biol Med. 1999 Feb;220(2):73-8. doi: 10.1046/j.1525-1373.1999.d01-12.x. Proc Soc Exp Biol Med. 1999. PMID: 10049099 Review. - Splicing in action: assessing disease causing sequence changes.
Baralle D, Baralle M. Baralle D, et al. J Med Genet. 2005 Oct;42(10):737-48. doi: 10.1136/jmg.2004.029538. J Med Genet. 2005. PMID: 16199547 Free PMC article. Review.
Cited by
- RNA splicing during terminal erythropoiesis.
Conboy JG. Conboy JG. Curr Opin Hematol. 2017 May;24(3):215-221. doi: 10.1097/MOH.0000000000000329. Curr Opin Hematol. 2017. PMID: 28118223 Free PMC article. Review. - IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions.
Koczorowska MM, Kwasniewska A, Gozdzicka-Jozefiak A. Koczorowska MM, et al. Exp Ther Med. 2011 Jan;2(1):149-156. doi: 10.3892/etm.2010.174. Epub 2010 Dec 2. Exp Ther Med. 2011. PMID: 22977483 Free PMC article. - Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.
Salomonis N, Schlieve CR, Pereira L, Wahlquist C, Colas A, Zambon AC, Vranizan K, Spindler MJ, Pico AR, Cline MS, Clark TA, Williams A, Blume JE, Samal E, Mercola M, Merrill BJ, Conklin BR. Salomonis N, et al. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10514-9. doi: 10.1073/pnas.0912260107. Epub 2010 May 24. Proc Natl Acad Sci U S A. 2010. PMID: 20498046 Free PMC article. - Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis.
Perrotta S, Della Ragione F, Rossi F, Avvisati RA, Di Pinto D, De Mieri G, Scianguetta S, Mancusi S, De Falco L, Marano V, Iolascon A. Perrotta S, et al. Haematologica. 2009 Dec;94(12):1753-7. doi: 10.3324/haematol.2009.010124. Epub 2009 Jul 16. Haematologica. 2009. PMID: 19608679 Free PMC article. - Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.
Hou VC, Lersch R, Gee SL, Ponthier JL, Lo AJ, Wu M, Turck CW, Koury M, Krainer AR, Mayeda A, Conboy JG. Hou VC, et al. EMBO J. 2002 Nov 15;21(22):6195-204. doi: 10.1093/emboj/cdf625. EMBO J. 2002. PMID: 12426391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources